# Exploring the fibrinolytic potential of marine Actinoalloteichus caeruleus isolated from Bay of Bengal coast

**Authors:** Kothari Neeti Suresh, Subathra Devi. C

PMC · DOI: 10.1186/s12866-025-03815-w · BMC Microbiology · 2025-03-03

## TL;DR

This paper explores a marine bacteria from the Bay of Bengal that produces a powerful clot-dissolving enzyme, which could be useful for treating cardiovascular diseases.

## Contribution

The study reports the first isolation and characterization of fibrinolytic Actinoalloteichus caeruleus from marine water.

## Key findings

- A potent isolate (NK60) showed 93.12 ± 0.18% clot lysis activity.
- Actinoalloteichus caeruleus was identified as a rare marine actinomycetota with significant fibrinolytic potential.
- The enzyme has potential pharmacological value for managing coronary artery diseases.

## Abstract

One of the main causes of several cardiovascular diseases that have an elevated mortality rate globally is intravascular thrombosis. The current fibrinolytic enzymes, are quite expensive and have a lot of side effects, thus it is necessary to develop alternate, economical techniques for the low-cost manufacture of these vital enzymes. Microbial fibrinolytic enzymes have the capacity to break up these clots and are relatively cheaper with minimal side effects and quick growth rate. Marine actinomycetota are the most prolific prokaryotes, which are capable of synthesizing novel secondary metabolites and are of industrial importance in pharmaceutical and various other industries. Thus, the objective of the research is to isolate, screen and characterize fibrinolytic protease producing actinomycetota from marine samples.

In this study, 35 actinomycetota have been successfully isolated from marine water and sediment samples. Among them, 12 isolates were protease positive and on secondary screening 5 isolates showed fibrinolytic activity. Out of the 5 isolates, one potent isolate’s clot lysis activity was found out to be 93.12 ± 0.18% and its fibrinolytic potential was determined on fibrin agar plates. Based on the morphological, physiological, biochemical, and molecular analysis, the potent strain (NK60) was identified as Actinoalloteichus caeruleus.

In this present study, a rare actinomycetota has been isolated from the Bay of Bengal coast. This is the first study reporting the potent fibrinolytic activity of A. caeruleus, isolated from marine water. This clot-busting enzyme has significant pharmacological value in the management of coronary artery diseases. In the near future, A. caeruleus can serve as an explicit source for commercial production of fibrinolytic enzymes.

## Linked entities

- **Species:** Actinoalloteichus caeruleus (taxon 2893586)

## Full-text entities

- **Diseases:** cardiovascular diseases (MESH:D002318), coronary artery diseases (MESH:D003324), intravascular thrombosis (MESH:D013927)
- **Chemicals:** agar (MESH:D000362)
- **Species:** A. caeruleus [taxon 195949], Actinoalloteichus caeruleus (species) [taxon 2893586], Nostoc sp. K60 (species) [taxon 2662548]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11874669/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11874669/full.md

## References

7 references — full list in the complete paper: https://tomesphere.com/paper/PMC11874669/full.md

---
Source: https://tomesphere.com/paper/PMC11874669